Business · 18/03/1998

FDA Requests Comments on International Drug Scheduling for Dihydroetorphine, Ephedrine, and Remifentanil

The US Food and Drug Administration (FDA) is seeking public input on the potential abuse liability, actual abuse, and trafficking of three psychotropic substances, which will inform the US response to the World Health Organization's (WHO) consideration of international restrictions.